Page last updated: 2024-10-17

n(1)-acetylspermidine and Carcinoma, Renal Cell

n(1)-acetylspermidine has been researched along with Carcinoma, Renal Cell in 1 studies

N(1)-acetylspermidine : An acetylspermidine having the acetyl group at the N1-position.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pine, MJ1
Huben, RP1
Pegg, AE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Urinary Excretion of Acetylamantadine by Cancer Patients[NCT02277938]120 participants (Anticipated)Observational2013-08-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for n(1)-acetylspermidine and Carcinoma, Renal Cell

ArticleYear
Production of N1-acetyl spermidine by renal cell tumors.
    The Journal of urology, 1989, Volume: 141, Issue:3

    Topics: Animals; Carcinoma, Renal Cell; Carmustine; Eflornithine; Female; Kidney Neoplasms; Mice; Mice, Inbr

1989